Tag Archives: EPO

HUMAN GENOME SCIENCES v. ELI LILLY – Increased European Harmony?

By Paul Cole, European Patent Attorney, Lucas & Co – Warlingham, UK Judgement – Human Genome Sciences Inc (Appellant) v Eli Lilly and Company (Respondent) The above proceedings relate to European Patent (UK) 0,939,804 concerning a new  human  protein called Neutrokine-α. … Continue reading

Posted in EP and UK Practice | Tagged , , , , , , | 1 Comment

EPO Ruling On Inventiveness Of Drug Polymorphs

Thank you to Dr. Stefan Danner, a German and European Patent Attorney at DHS Patentanwaltsgesellschaft mbH in Munich for letting us post the current issue of the biotech IP newsletter dealing with the recent EPO decision concerning the patentability of … Continue reading

Posted in EP and UK Practice | Tagged , , , , , , , , , , | Leave a comment

Decision of the EPO Enlarged Board of Appeal – Sexual Crossing and Selection of Plants is Not Patentable Even When Using DNA Markers

The following is a contribution from Verena Simpson PhD of Zacco Denmark A/S. G 0001/08 The core of the Decision 1. A non-microbiological process for the production of plants which contains or consists of the steps of sexually crossing the … Continue reading

Posted in EP and UK Practice | Tagged , , , , | Leave a comment

One step ahead and one step backward for the EU patent

The following is a contribution from Camilla Rendal Nielsen of Zacco Denmark A/S 1.   The EU Competiveness Council have authorised “enhanced cooperation” in the area of unitary patent protection, and. 2.   The EU court now states that the proposed Patents Court … Continue reading

Posted in Non-U.S. Practice | Tagged , , , , , , , , , , | Leave a comment